“…Since 1968, more than 69 cases of ICC administration errors have been documented. [7][8][9][10][11] However, the incidence is likely higher due to under-reporting. Most reported errors have been inadvertent ICC administration of an injection intended to be parenterally administered, including bortezomib, doxorubicin, daunorubicin, dactinomycin, videsine, and vincristine.…”